author-photo

Wojciech Niezychowski

Pfizer

31

Papers

1959

Citations

Citation Trend

Filter By

Papers (25) Sort By

Journal Conference Others

Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials.

2021 Alimentary Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Long-term safety and tolerability of oral tofacitinib in patients with Crohn’s disease: results from a phase 2, open-label, 48-week extension study

2019 Alimentary Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (19)
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

2017 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (659)
Tofacitinib for Maintenance Therapy in Patients With Active Ulcerative Colitis in the Phase 3 OCTAVE Sustain Trial: Results by Local and Central Endoscopic Assessments: 607

2017 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (5)
Efficacy and safety of oral tofacitinib as induction therapy in patients with moderate-to-severe ulcerative colitis: results from 2 phase 3 randomised controlled trials

2017 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (14)
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials

2017 Gut
Show All
- Source
- Cite
- Save
Citations (186)
OP031 Long-term safety and tolerability of oral tofacitinib in patients with Crohn's disease: results from a phase 2 open-label 48-week extension study

2017 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (0)
Pharmacokinetics and Exposure-Response of Tofacitinib in a Phase 3 Maintenance Study in Ulcerative Colitis Patients

2017 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (3)
767 Efficacy and Safety of Oral Tofacitinib As Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis: Results From Two Phase 3 Randomized Controlled Trials

2016 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (20)
Mo1780 Tofacitinib Pharmacokinetics and Durability of Drug Exposure in Moderate to Severe Crohn's Disease Patients in Phase 2 Induction and Maintenance Studies

2016 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (1)